Both AR-42 and, to a lesser extent, SAHA have been shown to decrease Akt phosphorylation in prostate cancer cells [20] attributable to the disruption of HDAC-protein phosphatase-1 (PP1) complexes leading to increased PP1-Akt association [21]. The gene discussed is HDAC9; the disease is prostate cancer.